When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AQST - Aquestive: Continues To Evolve Into A Promising Long-Term Investment
Aquestive Therapeutics Inc.
Aquestive Therapeutics (AQST) continues to evolve into a promising long-term investment. The company has completed its Libervant rolling NDA and received FDA approval for Exservan in ALS. In addition, Aquestive reported more than 50% growth of Sympazan shipments to retailers in Q3. What is more, the company has secured about $35M in funding from a recent secondary offering. Meanwhile, Aquestive continues to collect strong royalties and manufacturing revenue from their partnered products. Despite the recent spike in share price, I still believe AQST is undervalued and worthy of a long-term investment.